NIH Not Ready to Buy Trump’s Hype on COVID-19 Convalescent Plasma, Citing ‘Insufficient’ Data
The FDA authorized treating the coronavirus with blood from recovered patients last week, but the NIH says not so fast.

Guillermo Legaria/Getty
Get the Cheat Sheet newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
A panel of experts convened by the National Institute of Health issued a statement Tuesday directly contradicting the Food and Drug Administration and the president’s claim that convalescent plasma has been proven to be effective in treating COVID-19 patients. According to the NIH panel, data indicating convalescent plasma can treat COVID-19 is “insufficient.” The FDA granted an emergency authorization for the use of the substance, gleaned from the blood of coronavirus survivors, just last week. President Donald Trump touted a statistic saying that the plasma was “proven to reduce mortality by 35 percent.” Scientists have called that figure misleading because the study that made the finding has not yet been peer reviewed or published, nor did it make use of a control group given a placebo, making it neither randomized nor controlled, the gold standard of medical research. The FDA’s commissioner Stephen Hahn has admitted he overstated convalescent plasma’s benefits as well. The NIH panel found that there were “currently no data from well-controlled, adequately powered randomized clinical trials” and therefore “insufficient data to recommend either for or against the use of convalescent plasma for the treatment of COVID-19.”
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation